Capital Product Partners L.P. Q2 2024 Results Filed

Ticker: CCEC · Form: 6-K · Filed: Aug 2, 2024 · CIK: 1392326

Sentiment: neutral

Topics: earnings, financial-results, foreign-private-issuer

Related Tickers: CPLP

TL;DR

CPLP dropped Q2 2024 earnings results on 8/2, filed as a 6-K.

AI Summary

Capital Product Partners L.P. (CPLP) filed a 6-K report on August 2, 2024, attaching a press release detailing their financial results for the second quarter ended June 30, 2024. The filing indicates that CPLP is a foreign private issuer and will file annual reports under Form 20-F.

Why It Matters

This filing provides investors with the latest financial performance data for Capital Product Partners L.P., crucial for assessing the company's operational health and investment potential.

Risk Assessment

Risk Level: low — This is a routine filing of financial results, not indicating any new or unusual risks.

Key Players & Entities

FAQ

What is the primary purpose of this 6-K filing?

The primary purpose is to attach a press release announcing Capital Product Partners L.P.'s financial results for the second quarter of 2024, ended June 30, 2024.

What form does Capital Product Partners L.P. use for its annual reports?

Capital Product Partners L.P. files its annual reports under cover of Form 20-F.

Who signed this report on behalf of Capital Product Partners L.P.?

The report was signed by Gerasimos (Jerry) Kalogiratos, on behalf of Capital GP L.L.C., the general partner of Capital Product Partners L.P.

On what date was this 6-K report filed?

This 6-K report was filed on August 2, 2024.

What period do the financial results announced in the attached press release cover?

The financial results announced in the attached press release cover the second quarter of 2024, which ended on June 30, 2024.

Filing Stats: 177 words · 1 min read · ~1 pages · Grade level 9 · Accepted 2024-08-02 16:10:55

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CAPITAL PRODUCT PARTNERS L.P. Dated: August 2, 2024 By: Capital GP L.L.C., its general partner /s/ Gerasimos (Jerry) Kalogiratos Name: Gerasimos (Jerry) Kalogiratos Title: Chief Executive Officer of Capital GP L.L.C.

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing